Uterine Pathology II Flashcards

(52 cards)

1
Q

type 1 endometrium epithelium adenocarcinoma

A

glandular - endometroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

type 2 endometrium epithelium adenocarcinoma

A

surface - non-endometroid

-papillary serous carcinoma
MMMT - carcinomcarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

myometrium neoplasms

A

leiomyoma

leiomyosarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

endometroid adenocarcinoma

A

type 1

80% of endometrial cancer

peak age 45-55yo
with conditions of unopposed estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mutations of endometroid adenocarcinoma

A

type 1

PTEN - mutation

KRAS - microsatellite instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

conditions of unopposed estrogen

A
exogenous estrogen 10 years
endogenous - ovarian tumor
estrogen from peripheral conversion of androgen - PCOS, obesity, androgen tumor
infertility
diabetes
HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

abnormal bleeding, prolonged periods of 6 month duration

A

endometroid adenocarcinoma - type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

grade of endometroid adenocarcinoma

A

based on number of lumens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

tamoxifen

A

risk fx for type 1 - endometroid adenocarcinoma of uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

absence of PTEN stain

A

type 1 - endometroid adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

non-endometroid adenocarcinoma

A

type 2

  • all high grade and aggressive**
  • early lymph spread

papillary serous carcinoma

15% of endometrial carcinomas

post-menopausal disease**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cancer of endometrium post-menopause

A

type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mutation in p53

A

non-endometroid adenocarcinoma of endometrium - type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MMMT

A

malignant mixed mullerian tumor
carcinosarcoma

bulky polypoid mass

distinct epithelial and mesenchymal components**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

papillary architecture

A

serous carcinoma - type 2 non-endometroid adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

positive p53

A

non-endometroid adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

precursor to type 1

A

hyperplasia / EIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

precursor to type 2

A

endometrial intraepithelial carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

african america, thin, atrophy

A

type 2 endometrial cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

grade and stage of endometrium cancer

A

grade - differentiation
1 - well
2 - moderate
3 - poor

stage - location
1 - corpus uteri
2 - corpus and cervix
3 - extends outside uterus 
4 - outside true pelvis or mucosa of bladder/rectum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

all type II nonendometroid carcinomas

22
Q

carcinosarcoma

A

MMMT

adenocarcinoma and sarcoma together

bad - aggressive

23
Q

surgery for uterine carcinoma

A

unless grade 1 type 1 endometroid adenocarcinoma

and fertility preservation
or poor surgical candidate

24
Q

trial for hormone therapy

A

type 1 endometroid adenocarcinoma
fertility preservation
poor surgical candidate

do therapy instead of surgery**

25
post-menopausal bleeding
common presentation of type 1 endometroid adenocarcinoma
26
omenectomy
if non-endometroid adenocarcinoma (type 2) - serous | OR carcinosarcoma
27
ifosfamide
adjuvant therapy - if carcinomsarcoma with rhabdomyosarcoma elements
28
candidate for lynch syndrome screening
``` age <50 bethesda guieline criteria tumor with lymphocytes lower uterine origin concurrent ovarian cancer ```
29
stroma cancer of uterus
B9 stromal nodule endometrial stroma sarcoma adenosarcoma 2 and 3 - bad - malignant
30
large sessile polyp protruding through cervical os
adenosarcoma
31
endometrial stromal nodule
benign - but need to differentiate from sarcoma
32
spindle cell neoplasma
endometrial stromal sarcoma 5 year survival 50%
33
CD10 IPX stain
endometrial stromal sarcoma
34
sheets of blue cells
stromal cells | -endometrial stromal sarcoma
35
MED12 mutation
unique to smooth m -leiomyoma and leiomyosarcoma
36
leiomyoma
benign smooth muscle neoplasm fibroid
37
leiomyoma vs. leiomyosarcoma
both have MED 12 mutation distinguish by number of mitotic figures**
38
mets for leiomyosarcoma
blood vessels - hematogenous spread
39
location of leiomyoma
determines the symptoms - bleeding - submucosa - pelvic fullness - large mass - urinary frequency - pressure against bladder - infertility and miscarriage may occur
40
MED12 with numerous mitotic figures on histo
leiomyosarcoma
41
dilation and curettage
dilation of cervix | scraping of uterine wall
42
salpingitis
inflammation of fallopian tube with PID
43
acute bacterial salpingitis
suppurative - pus 60% gonnococcus 40% chlamydia -differentiate with culture
44
pyosalpinx and hydrosalpinx
tube scar shut - with salpingitis
45
complications of saplingitis
adhesions infertility ectopic pregnancy
46
paratubal cysts
arise in mullerian remnants at fimbriated end of tube or in broad ligament translucent, thin walled, unicameral aka hydatid cysts of morgagni
47
ectopic pregnancy
abnormal implantation -with PID, adhesions, or endometriosis tube ruptures 12 weeks - hemorrhage life threatening section of tube - shows chorionic villi
48
most common site of ectopic
ampulla of tube 70%
49
endometrium hypersecretory with no chorionic vili
possible ectopic pregnancy
50
high risk for ectopic
``` previous ectopic tubal surgery tubal ligation IUD use PID multiple sex partners smoking ```
51
methotrexate
tx option for ectopic - destroys fetal tissue
52
fallopian adenocarcinoma
possible source of high grade serous carcinoma of ovary